Status:
COMPLETED
A Study to Assess the Feasibility of Screening for SARS-CoV-2 Among Healthy Workers
Lead Sponsor:
Miltenyi Biomedicine GmbH
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
This is a prospective, epidemiological, cohort study to assess the feasibility of screening healthy asymptomatic workers for the presence of severe acute respiratory syndrome SARS-CoV-2 by pharyngeal ...
Detailed Description
This study has been designed to assess the feasibility of screening asymptomatic workers and to investigate the extent of infection, as determined by pharyngeal swaps analysis and immune response agai...
Eligibility Criteria
Inclusion
- Healthy workers asymptomatic for SARS-CoV-2
- Ability to consent with the study and its procedures
- Age above 18 years old
- Full time employee on site at least 3 full working days a week
- Working in a shared office/lab/manufacturing environment where at least 3 employees are present and/or having frequent contact with others i.e reception area, transportation and delivery areas.
Exclusion
- Workers presenting symptoms that could be signs of a SARS-CoV-2 infection such as:
- fever ≥38°C
- chills
- fatigue
- muscle ache (myalgia)
- sore throat
- cough
- runny nose (rhinorrhea)
- shortness of breath (dyspnea)
- wheezing
- chest pain
- other respiratory Symptoms
- headache
- nausea/vomiting
Key Trial Info
Start Date :
April 22 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 17 2020
Estimated Enrollment :
417 Patients enrolled
Trial Details
Trial ID
NCT04405466
Start Date
April 22 2020
End Date
December 17 2020
Last Update
May 25 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Miltenyi Biotec B.V. & Co. KG
Bergisch Gladbach, North Rhine-Westphalia, Germany, 51429